Cetera Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
Other funds holding PJP
PAM
FDCDDQ
DBIA
Cetera Advisors's PJP Position: Q1 2023 in Review
Cetera Advisors sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2023, closing a stake of 2,966 shares — an estimated $233K sold.
Cetera Advisors first reported a position in PJP in Q2 2014 and held it in 17 quarters. The position peaked at $539K in Q3 2021. 87 funds tracked by Wall St. Rank hold PJP as of Q1 2023.
- Cetera Advisors reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2023 after selling out during the quarter.
- Cetera Advisors sold 2,966 Invesco Pharmaceuticals ETF shares in Q1 2023, an estimated $233K.
- Cetera Advisors first reported a position in Invesco Pharmaceuticals ETF in Q2 2014 and held it in 17 quarters.
- Cetera Advisors's Invesco Pharmaceuticals ETF position peaked at $539K in Q3 2021.
- 87 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2023.
Based on Cetera Advisors's 13F filing for Q1 2023, filed 15 May 2023.